Back
Halozyme Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
HALO
Halozyme Therapeutics
Last Price:
49.01
Seasonality Move:
17.34%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.26 | Buy |
| 20-day SMA: | 53.24 | Sell |
| 50-day SMA: | 54.79 | Sell |
| 200-day SMA: | 49.21 | Sell |
| 8-day EMA: | 48.74 | Buy |
| 20-day EMA: | 51.64 | Sell |
| 50-day EMA: | 53.83 | Sell |
| 200-day EMA: | 50.48 | Sell |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.25 | Sell |
| Relative Strength Index (14 RSI): | 43.09 | Sell |
| Chaikin Money Flow: | 3002123 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.05 - 58.35) | Sell |
| Bollinger Bands (100): | (51.29 - 60.61) | Sell |
Halozyme Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
- Halozyme Therapeutics share price is 49.00 while HALO 8-day simple moving average is 48.26, which is a Buy signal.
- The stock price of HALO is 49.00 while Halozyme Therapeutics 20-day SMA is 53.24, which makes it a Sell.
- Halozyme Therapeutics 50-day simple moving average is 54.79 while HALO share price is 49.00, making it a Sell technically.
- HALO stock price is 49.00 and Halozyme Therapeutics 200-day simple moving average is 49.21, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
51
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a Buy
The current Halozyme Therapeutics [HALO] share price is $49.00. The Score for HALO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
6.23B
Price in USD:
49.00
Share Volume:
4.54M
Halozyme Therapeutics 52-Week Range
52-Week High:
65.53
52-Week Low:
33.15
Buy
51
Halozyme Therapeutics (HALO)
is a Buy
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?
The Halozyme Therapeutics stock price is 49.00 USD today. -
Will HALO stock go up or go down?
Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Halozyme Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is not overvalued.
Is Halozyme Therapeutics Stock a Buy?
- Halozyme Therapeutics share price is 49.00 while HALO 8-day exponential moving average is 48.74, which is a Buy signal.
- The stock price of HALO is 49.00 while Halozyme Therapeutics 20-day EMA is 51.64, which makes it a Sell.
- Halozyme Therapeutics 50-day exponential moving average is 53.83 while HALO share price is 49.00, making it a Sell technically.
- HALO stock price is 49.00 and Halozyme Therapeutics 200-day simple moving average is 50.48, creating a Sell signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
- HALO Moving Average Covergence Divergence (MACD) indicator is -2.25, suggesting Halozyme Therapeutics is a Sell
- Halozyme Therapeutics Relative Strength Index (RSI) is 43.09, which suggest Halozyme Therapeutics is oversold
- The Bollinger Bands (25) for Halozyme Therapeutics is (47.05 - 58.35), which suggest Halozyme Therapeutics is a Sell
- The Bollinger Bands (100) for Halozyme Therapeutics is (51.29 - 60.61), which suggest Halozyme Therapeutics is a Sell
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.